Boost to Melanoma Services in the Riverina
12 December 2019
Melanoma patients and their families throughout the Riverina region will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia..
The merger was announced at the 10th Anniversary Celebrations for the Amie St Clair Melanoma Trust, which was formed by Annette and Peter St Clair in memory of their daughter Amie who passed away from melanoma when she was just 23 years old.
It will provide immediate benefits by doubling the level of services provided to melanoma patients in the Riverina, including:
- Increased capacity of the free melanoma nursing services;
- The establishment of clinical trials in Wagga Wagga;
- Opportunities for melanoma patients within the region to contribute to MIA research;
- Melanoma Education opportunities – both professional (GPs/Clinics) and community-based through the SunSafe Student Ambassador program.
The merged entity will retain its local office presence in Wagga Wagga, as well as the dedicated service of both Annette and Peter St Clair. Importantly, the legacy of Amie St Clair will be maintained.
Annette St Clair said she is excited by the opportunities created through MIA. ‘Pete and I just can’t believe we will have clinical trials established here and we are really excited that MIA is using the Amie St Clair Trust model as the framework to increase services in other parts of regional Australia,'
‘Our wonderful volunteers have worked so hard to build the Amie St Clair Melanoma Trust over the last 10 years, and this partnership with MIA will significantly increase melanoma services for the next 10 years.’
Melanoma Institute Australia CEO Matthew Browne attended the 10th Anniversary Celebrations and paid tribute to the tireless work of Annette and Peter St Clair, plus the all the volunteers, in raising awareness of melanoma and supporting local patients and their families.
‘We love what the Amie St Clair Melanoma Trust has been doing and together we have built a strong relationship over the past few years,’ Mr Browne said. ‘Our shared vision is zero deaths from melanoma, no matter where you live, and this is a fantastic opportunity to enhance the effective delivery of treatment and support services to melanoma patients in this region.
‘We can then go to Government with a proven collaborative model and hopefully extend melanoma support services to other regional centres as well.’
The newly merged entity will be officially launched at an event in Wagga on 27 February 2020 and its first major fundraising event will be Melanoma March Wagga on 15 March at Apex Park.
Pictured in photo: Annette St Clair and Moo, from Amie St Clair Melanoma Trust
Melanoma Patients Australia Symposium - Webinar 2
Join us at the 2nd Melanoma Patients Australia webinar 'Psychological Health & Wellbeing'.
City2Surf 2020
You're invited to be a C2S charity superstar, and together we can run over melanoma!
City2Surf 2020
Join in the fun of the virtual event, and together we can run over melanoma!
Top melanoma experts from MIA
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Melanoma Supportive Care Needs research study.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
New data reveals long-term benefit of adjuvant therapy for Stage III melanoma.
New online melanoma risk calculators critical to saving lives
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
Professor Richard Scolyer receives University of Sydney Alumni Award.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
Uniting together despite the distance
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
Professor Richard Scolyer recognised in The Pathologist's 2020 Power List.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
Important Update: Masks required at Poche Centre
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
A Critical Nexus:The Clinician and the Researcher.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
New online calculator launched to determine risk of spread of melanoma
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Queen's Birthday Honour for Professor Georgina Long
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
Danny's inspiring survival story
“I had a complete response within about six months. All of my tumours disappeared."
MIA in the spotlight at ASCO virtual conference
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
Professor Richard Scolyer achieves h-index of 100
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
See how we connected at Melanoma March Virtual 2020
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
Melanoma meets its match.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
Next Steps for National Screening Program for Melanoma
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.